First to Report Research

Jain AB, Buckles JAC, Adu D, Michael J, Mackintosh P, McMaster P. Long-term results of cyclosporine renal transplantation from a single center. Transplant Proc 20(3 Suppl 3):82-85, 1988.

Jain AB, Venkataramanan R, Cadoff E, Fung JJ, Todo S, Krajack A, Starzl TE. Effect of hepatic dysfunction and T-tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc 22(1):57-59, 1990.

Jain AB, Fung JJ, Todo S, Alessiani M, Takaya S, Abu-Elmagd K, Tzakis AG, Starzl TE. Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc 23(1 Pt.2):928-930, 1991.

Jain AB, Fung JJ, Tzakis AG, Venkataramanan R, Abu-Elmagd K, Alessiani M, Reyes J, Irish W, Warty V, Mehta S, Todo S, Starzl TE. Comparative study of cyclosporine and FK 506 dosage requirements in adults and pediatric orthotopic liver transplant patients. Transplant Proc 23:2763-2766, 1991.

Jain AB, Todo S, Fung JJ, Venkataramanan R, Day R, Bryant J, Abu-Elmagd KM, Alessiani M, Takaya S, Tzakis A, Starzl TE. Correlation of rejection episodes with FK 506 dosage, FK 506 level and steroid following primary orthotopic liver transplant. Transplant Proc 23(6):3023-3025, 1991.

Jain AB, Venkataramanan R, Todo S, Abu-Elmagd K, Fung JJ, Warty V, Tzakis A, Reyes J, Alessiani M, Starzl T. Intravenous, oral pharmacokinetics and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc 24(3):1181-1182, 1992.

Jain AB, Venkataramanan R, Lever J, Warty V, Fung JJ, Todo S, Starzl TE. FK 506 and pregnancy in liver transplant patients. Transplantation 56(3):751, 1993.

Jain AB, Abu-Elmagd K, Abdallah H, Warty V, Fung JJ, Todo S, Starzl TE, Venkataramanan R. Pharmacokinetics of FK 506 in liver transplant recipients following continuous intravenous infusion. J Clin Pharmacol 33(7):606-611, 1993.

Jain AB. Incidence and severity of rejection under Alpha Interferon for viral hepatitis following liver transplantation. Liver update, Function and Disease 7(1):5, 1993.

Jain AB, Pinna A, Fung JJ, Warty VS, Singhal AK, Lever J, Venkataramanan R. Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. Transplantation 60:512-514, 1995.

Jain AB, Hamad I, Rakela J, Dodson F, Kramer D, Demetris J, McMichael J, Starzl TE, Fung JJ. A prospective randomized trial of tacrolimus and Prednisone versus tacrolimus, Prednisone and Mycophenolate Mofetil in primary adult liver transplant recipients: an interim report. Transplant Proc (33):1342-1344, 2001.

Brown P, Buckles JAC, Jain AB, McMaster P. Successful cadaveric renal transplant from a donor who died of cyanide poisoning. Brit Med J 294:1325, 1987.

Starzl TE, Todo S, Fung JJ, Demetris AJ, Venkataramanan R, Jain AB. FK 506 for liver, kidney, and pancreas transplantation. Lancet 2:1000-1004, 1989.

Fung JJ, Todo S, Jain AB, McCauley J, Alessiani M, Scotti C, Starzl TE. Conversion of liver allograft recipients with cyclosporine-related complications from cyclosporine to FK 506. Transplant Proc 22(1):6-12, 1990.

Shapiro R, Fung JJ, Jain AB, Parks P, Todo S, Starzl TE. The side effects of FK 506 in humans. Transplant Proc 22(1):35-36, 1990.

Van Thiel DH, Iqbal M, Jain AB, Fung JJ, Todo S, Starzl TE. Gastrointestinal and metabolic problems associated with immunosuppression with either cyclosporine or FK 506 in liver transplantation. Transplant Proc 22(1):37-40, 1990.

Venkataramanan R, Jain AB, Cadoff E, Fung JJ, Warty V, Krajack A, Imventarza O, Todo S, Fung JJ, StarzlTE. Pharmacokinetics of FK 506 Preclinical and Clinical Studies. Transplant Proc 22(1):52-56, 1990.

Todo S, Fung JJ, Starzl TE, Tzakis A, Demetris AJ, Kormos R, Jain AB, Alessiani M, Takaya S, Shapiro R. Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg 212(3):295-307, 1990.

Starzl TE, Fung JJ, Jordan M, Shapiro R, Tzakis A, McCauley J, Johnston J, Iwaki Y, Jain AB, Alessiani M, Todo S. Kidney transplantation under FK 506. JAMA 264:63-67, 1990.

Steeves M, Abdallah HY, Venkataramanan R, Burckart GJ, Ptachcinski RJ, Abu-Elmagd K, Jain AB, Fung JJ, Todo S, Starzl TE. In-vitro interaction of a novel immunosuppressant, FK 506, and antacids. J Pharm Pharmacol 43:574-577, 1991.

Alessiani M, Kusne S, Fung JJ, Torre-Cisneros J, Jain AB, Abu-Elmagd K, Takaya S, Cillo U, Martin M, Todo S, Starzl TE. CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. Transplant Proc 23:3035-3037, 1991.

Eidelman BH, Abu-Elmagd K, Wilson J, Fung JJ, Alessiani M, Jain AB, Takaya S, Todo SN, Tzakis AG, Van Thiel DH, Shannon W, Starzl TE. Neurological complications of FK 506. Transplant Proc 23(6):3175-3178, 1991.

Tzakis AG, Reyes J, Todo S, Green M, Ohya T, Jain AB, Abu-Elmagd K, Alessiani M, Fung JJ, Starzl TE. FK 506 versus cyclosporine in pediatric liver transplantation. Transplant Proc 23(6):3010-3015, 1991.

Takaya S, Bronsther O, Todo S, Abu-Elmagd K, Jain AB, Alessiani M, Madariaga J, Marino IR, Selby R, Fung JJ, Gordon RD, Starzl TE. Retransplantation of liver: A comparison of FK 506-and cyclosporine-treated patients. Transplant Proc 23(6):3026-3028, 1991.

Felser I, Wagner S, Depee J, Johnson N, Staschak S, Jain AB, Fung JJ, Starzl TE. Changes in quality of life following conversion from CYA to FK 506 in orthotopic liver transplant patients. Transplant Proc 23(6):3032-3034, 1991.

Todo S, Tzakis AG, Abu-Elmagd K, Reyes J, Fung JJ, Casavilla A, Nakamura K, Yagihashi A, Jain AB, Murase N, Iwaki Y, Demetris AJ, Van Thiel DH, Starzl TE. Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation 53(2):369-376, 1992.

Manez R, Martin M, Raman D, Silverman D, Jain AB, Warty V, Gonzalez-Pinto I, Kusne S, Starzl TE. Fluconazole therapy in transplant recipients receiving FK 506. Transplantation 57(10):1521-1523, 1994.

Reyes J, Jain AB, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung JJ. Long-term results after conversion from Cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Transplantation 69(12):2573-2580, 2000.

Demetris AJ, Ruppert K, DeFrances M, Minervini M, Nalesnik M, Randhawa P, Wu T, El-Magd K, Fontes P A, Cacciarelli TV, Jain AB, Marsh JW, Geller DA, Dvorchik I, Starzl TE and Fung JJ. Prospective evaluation of the Banff Schema for acute liver allograft rejection under real time/life conditions. Transplantation 2002 (in press).